Literature DB >> 22591447

Mortality of HIV-infected and uninfected children in a longitudinal cohort in rural south-west Uganda during 8 years of follow-up.

Mary Munyagwa1, Kathy Baisley, Jonathan Levin, Michael Brian, Heiner Grosskurth, Dermot Maher.   

Abstract

OBJECTIVES: To determine the impact of HIV on child mortality and explore potential risk factors for mortality among HIV-infected and HIV-exposed uninfected children in a longitudinal cohort in rural Uganda.
METHODS: From July 2002 to March 2010, HIV-infected and HIV-exposed uninfected children aged 6 weeks-13 years were enrolled in an open population-based clinical cohort. Antiretroviral therapy (ART) was introduced in 2005. Clinical and laboratory data were collected every 3 months. Person-years at risk were calculated from time of enrolment until earliest date of ART initiation, death or last visit. Cox regression was used to estimate hazard ratios (HR) for mortality.
RESULTS: Eighty-nine (30.2%) HIV-infected and 206 (69.8%) HIV-exposed but uninfected children were enrolled. Twenty-one children died. The mortality rate was six times higher in ART-naive HIV-infected children than in HIV-exposed but uninfected children (HR = 6.4, 95% CI = 2.4-16.6). Among HIV-infected children, mortality was highest in those aged <2 years. Decreasing weight-for-age Z (WAZ) score was the strongest risk factor for mortality among HIV-infected children (HR for unit decrease in WAZ = 2.6, 95% CI = 1.6-4.1). Thirty-five children (aged 7 months-15.6 years; median, 5.4 years) started ART.
CONCLUSIONS: Mortality among HIV-infected children was highest among those aged <2 years. Intensified efforts to prevent mother-to-child transmission of HIV and ensure early HIV diagnosis and treatment are required to decrease child mortality caused by HIV in rural Africa.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22591447     DOI: 10.1111/j.1365-3156.2012.03000.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  16 in total

Review 1.  Optimal time for initiating antiretroviral therapy (ART) in HIV-infected, treatment-naive children aged 2 to 5 years old.

Authors:  Nandi Siegfried; Mary-Ann Davies; Martina Penazzato; Lulu M Muhe; Matthias Egger
Journal:  Cochrane Database Syst Rev       Date:  2013-10-10

Review 2.  Pediatric HIV/AIDS in sub-Saharan Africa: emerging issues and way forward.

Authors:  A C Ubesie
Journal:  Afr Health Sci       Date:  2012-09       Impact factor: 0.927

3.  Weight as predictors of clinical progression and treatment failure: results from the TREAT Asia Pediatric HIV Observational Database.

Authors:  Azar Kariminia; Nicolas Durier; Gonzague Jourdain; Suneeta Saghayam; Chau V Do; Lam Van Nguyen; Rawiwan Hansudewechakul; Pagakrong Lumbiganon; Kulkanya Chokephaibulkit; Khanh Huu Truong; Virat Sirisanthana; Vibol Ung; Saphonn Vonthanak; Jintanat Ananworanich; Nik Khairulddin Nik Yusoff; Nia Kurniati; Kamarul Azahar Razali; Moy Siew Fong; Revathy Nallusamy; Dewi Kumara Wati
Journal:  J Acquir Immune Defic Syndr       Date:  2014-09-01       Impact factor: 3.731

4.  Scaling up Pediatric HIV Testing by Incorporating Provider-Initiated HIV Testing Into all Child Health Services in Hurungwe District, Zimbabwe.

Authors:  Reuben Musarandega; Blessing Mutede; Agnes Mahomva; Wenceslas Nyamayaro; Angela Mushavi; Christina Lindan; Rhoderick Machekano
Journal:  J Acquir Immune Defic Syndr       Date:  2018-01-01       Impact factor: 3.731

5.  Nutritional and Immunological Correlates of Memory and Neurocognitive Development Among HIV-Infected Children Living in Kayunga, Uganda.

Authors:  Horacio Ruiseñor-Escudero; Itziar Familiar-Lopez; Alla Sikorskii; Nikita Jambulingam; Noelline Nakasujja; Robert Opoka; Judith Bass; Michael Boivin
Journal:  J Acquir Immune Defic Syndr       Date:  2016-04-15       Impact factor: 3.731

6.  Maternal HIV status associated with under-five mortality in rural Northern Malawi: a prospective cohort study.

Authors:  Menard L Chihana; Alison Price; Sian Floyd; Sebastian Mboma; Hazzie Mvula; Keith Branson; Jacqueline Saul; Basia Zaba; Neil French; Amelia C Crampin; Judith R Glynn
Journal:  J Acquir Immune Defic Syndr       Date:  2015-01-01       Impact factor: 3.731

7.  Description of the cascade of care and factors associated with attrition before and after initiating antiretroviral therapy of HIV infected children in a cohort study in India.

Authors:  Gerardo Alvarez-Uria
Journal:  PeerJ       Date:  2014-03-13       Impact factor: 2.984

8.  Poor clinical outcomes for HIV infected children on antiretroviral therapy in rural Mozambique: need for program quality improvement and community engagement.

Authors:  Sten H Vermund; Meridith Blevins; Troy D Moon; Eurico José; Linda Moiane; José A Tique; Mohsin Sidat; Philip J Ciampa; Bryan E Shepherd; Lara M E Vaz
Journal:  PLoS One       Date:  2014-10-20       Impact factor: 3.240

9.  Validation and calibration of a computer simulation model of pediatric HIV infection.

Authors:  Andrea L Ciaranello; Bethany L Morris; Rochelle P Walensky; Milton C Weinstein; Samuel Ayaya; Kathleen Doherty; Valeriane Leroy; Taige Hou; Sophie Desmonde; Zhigang Lu; Farzad Noubary; Kunjal Patel; Lynn Ramirez-Avila; Elena Losina; George R Seage; Kenneth A Freedberg
Journal:  PLoS One       Date:  2013-12-13       Impact factor: 3.240

10.  Paediatric HIV care in sub-Saharan Africa: clinical presentation and 2-year outcomes stratified by age group.

Authors:  Jihane Ben-Farhat; Marianne Gale; Elisabeth Szumilin; Suna Balkan; Elisabeth Poulet; Mar Pujades-Rodríguez
Journal:  Trop Med Int Health       Date:  2013-06-20       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.